Sanofi Decides to Stop Studies of Nurix-Partnered Experimental Drug
Photo: TokenPost
Nurix Therapeutics said Tuesday that its partner Sanofi had decided to stop studies of an experimental inflammatory disease therapy. NRIX shares entered Wednesday’s premarket session with losses from after the market closed Tuesday still in place. John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.
Source: TokenPost
